Glenmark Pharmaceuticals has informed regarding a Press Release dated April 07, 2015, titled ‘Glenmark receives final ANDA approval for Norethindrone Acetate and Ethinyl Estradiol Tablets USP, 0.5 mg/2.5 mcg and 1mg/5 mcg’.
The above information is a part of company’s filings submitted to BSE.